Roflumilast cream for plaque and nail psoriasis
Part of Skin clinical trials.
This trial tests a cream called roflumilast for people with plaque psoriasis on the body and nail psoriasis. It aims to see if the cream safely improves both skin and nails.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 12 years old or older.
- You need to have had stable psoriasis (on your body, not scalp) and stable nail psoriasis for at least 6 months.
- Nail psoriasis must affect 3 or more fingernails.
- You cannot use certain nail products (like gel or acrylic nails) during the study.
- Women who could become pregnant must use effective birth control and have negative pregnancy tests.
- You should not have taken certain other psoriasis medications or have certain health conditions (like severe depression, liver problems, or HIV).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicated foam (Roflumilast) in children with non-segmental vitiligo to see if it can improve skin color on the face and body. It is for patients aged 2 to 17 with small patches and at least some pigmented hair in the face patches.
This study tests an oral medicine called roflumilast for adults with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective when taken by mouth, and you can join if you have not used other systemic treatments recently.
This trial tests whether a medication called roflumilast can help psoriasis in skin folds (like armpits or groin) that hasn't improved with creams or ointments. Researchers want to see if this pill or oral treatment works better than standard care for these sensitive areas.
This trial tests a medicated foam called roflumilast to treat seborrheic dermatitis, a skin condition that causes redness, itching, and flaking. It may help people who have moderate to severe symptoms on their face, scalp, or body.
This study tests whether a new foam treatment (roflumilast) can safely reduce skin rashes, itching, and other skin problems caused by checkpoint inhibitor cancer drugs. If you've developed these skin side effects from immunotherapy, this trial may help ease your symptoms.
This study tests whether a new ointment called RSS0393 can safely and effectively treat plaque psoriasis (a common skin condition causing red, scaly patches). You would apply it to affected skin areas and be compared to people using a placebo (inactive cream) to see if the treatment works.
Hear when a new Nail Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.